Skip Nav Destination
Issues
July 2011
ISSN 0030-2414
EISSN 1423-0232
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2011, Vol. 80, No. 3-4
Editorial
Clinical Study
Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results
Subject Area:
Oncology
Nancy E. Kemeny; Lawrence Schwartz; Mithat Gönen; Adam Yopp; David Gultekin; Michael I. D’Angelica; Yuman Fong; Dana Haviland; Alexandra N. Gewirtz; Peter Allen; William R. Jarnagin
Oncology (2011) 80 (3-4): 153–159.
https://doi.org/10.1159/000324704
Predicting Hospital Mortality in Critically Ill Cancer Patients according to Acute Kidney Injury Severity
Subject Area:
Oncology
Alexandre Braga Libório; Krasnalhia Lívia S. Abreu; Geraldo B. Silva, Jr.; Rafael S.A. Lima; Adller G.C. Barreto; Orivaldo A. Barbosa; Elizabeth F. Daher
Oncology (2011) 80 (3-4): 160–166.
https://doi.org/10.1159/000329042
Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models
Subject Area:
Oncology
Kyung Kee Baek; Jung-Hoon Kim; Ji Eun Uhm; Se Hoon Park; Jeeyun Lee; Joon Oh Park; Young Suk Park; Won Ki Kang; Ho Yeong Lim
Oncology (2011) 80 (3-4): 167–174.
https://doi.org/10.1159/000327591
A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic Cancer
Subject Area:
Oncology
Jun Ho Yi; Jeeyun Lee; Se Hoon Park; Kyu Taek Lee; Jong Kyun Lee; Kwang Hyuck Lee; Dong Wook Choi; Seong-Ho Choi; Jin-Seok Heo; Do Hoon Lim; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Keunchil Park; Joon Oh Park
Oncology (2011) 80 (3-4): 175–180.
https://doi.org/10.1159/000328449
Clinical Translational Research
A High Proliferative Index of Recurrent Melanoma Is Associated with Worse Survival
Subject Area:
Oncology
Ting J. Tu; Michelle W. Ma; Stefano Monni; Amy E. Rose; Herman Yee; Farbod Darvishian; David Polsky; Russell S. Berman; Richard L. Shapiro; Anna C. Pavlick; Madhu Mazumdar; Iman Osman
Oncology (2011) 80 (3-4): 181–187.
https://doi.org/10.1159/000328518
Clinical Study
Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma
Subject Area:
Oncology
Norihiro Imai; Kenji Ikeda; Yuya Seko; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Oncology (2011) 80 (3-4): 188–194.
https://doi.org/10.1159/000328749
Clinical Translational Research
Certain Imidazotetrazines Escape O6-Methylguanine-DNA Methyltransferase and Mismatch Repair
Subject Area:
Oncology
Jihong Zhang; Malcolm F.G. Stevens; Marc Hummersone; Srinivasan Madhusudan; Charles A. Laughton; Tracey D. Bradshaw
Oncology (2011) 80 (3-4): 195–207.
https://doi.org/10.1159/000327837
Clinical Study
Adjuvant Chemotherapy for Small Bowel Adenocarcinoma after Curative Surgery
Subject Area:
Oncology
Dong Hoe Koo; Sung-Cheol Yun; Yong Sang Hong; Min-Hee Ryu; Jae-Lyun Lee; Heung-Moon Chang; Yoon-Koo Kang; Song-Cheol Kim; Duck-Jong Han; Young-Joo Lee; Tae Won Kim
Oncology (2011) 80 (3-4): 208–213.
https://doi.org/10.1159/000328506
Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma
Subject Area:
Oncology
Oncology (2011) 80 (3-4): 214–218.
https://doi.org/10.1159/000329078
Brief Report: Phase II Multicenter Study of Temozolomide in Patients with Cisplatin-Resistant Germ Cell Tumors
Subject Area:
Oncology
Oncology (2011) 80 (3-4): 219–222.
https://doi.org/10.1159/000329041
Letter to the Editor
Emerging Therapeutic Targets in Osteoncology
Subject Area:
Oncology
Oncology (2011) 80 (3-4): 223–224.
https://doi.org/10.1159/000327573
Clinical Translational Research
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study
Subject Area:
Oncology
Emanuele Sacanna; Toni Ibrahim; Michele Gaudio; Laura Mercatali; Emanuela Scarpi; Wainer Zoli; Patrizia Serra; Sara Bravaccini; Rossana Ricci; Luigi Serra; Dino Amadori
Oncology (2011) 80 (3-4): 225–231.
https://doi.org/10.1159/000327585
Polymorphisms of Estrogen Receptors: Risk Factors for Invasive Melanoma – A Prospective Study
Subject Area:
Oncology
Vincenzo de Giorgi; Serena Sestini; Alessia Gori; Celestina Mazzotta; Marta Grazzini; Susanna Rossari; Carmelo Mavilia; Emanuele Crocetti; Maria Luisa Brandi; Torello Lotti; Daniela Massi
Oncology (2011) 80 (3-4): 232–237.
https://doi.org/10.1159/000328321
Clinical Study
Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study
Subject Area:
Oncology
M. Bruzzone; M.G. Centurioni; P. Giglione; M. Gualco; D.F. Merlo; L. Miglietta; M. Cosso; F. Giannelli; P. Cristoforoni; M. Ferrarini
Oncology (2011) 80 (3-4): 238–246.
https://doi.org/10.1159/000328451
Review
Immunochemistry and Lung Cancer: Application in Diagnosis, Prognosis and Targeted Therapy
Subject Area:
Oncology
Oncology (2011) 80 (3-4): 247–256.
https://doi.org/10.1159/000329064
Clinical Study
High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients
Subject Area:
Oncology
Oncology (2011) 80 (3-4): 257–261.
https://doi.org/10.1159/000328795
Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer
Subject Area:
Oncology
Thomas Bachelot; Agathe Bajard; Isabelle Ray-Coquard; Jocelyne Provencal; David Coeffic; Cécile Agostini; Martial Boisseau; Régis Kaphan; Dominique Dramais; Corina Oprea; Rose-Marie Ferri-Dessens; Jean-Paul Guastalla; David Perol
Oncology (2011) 80 (3-4): 262–268.
https://doi.org/10.1159/000329066
Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
Subject Area:
Oncology
Alíz Nikolényi; Farkas Sükösd; László Kaizer; Erika Csörgő; András Vörös; Gabriella Uhercsák; Katalin Ormándi; György Lázár; László Thurzó; Thomas Brodowicz; Zsuzsanna Kahán
Oncology (2011) 80 (3-4): 269–277.
https://doi.org/10.1159/000329038
Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
Subject Area:
Oncology
Kaoru Tsuchiya; Mina Komuta; Yutaka Yasui; Nobuharu Tamaki; Takanori Hosokawa; Ken Ueda; Teiji Kuzuya; Jun Itakura; Hiroyuki Nakanishi; Yuka Takahashi; Masayuki Kurosaki; Yasuhiro Asahina; Nobuyuki Enomoto; Michiie Sakamoto; Namiki Izumi
Oncology (2011) 80 (3-4): 278–288.
https://doi.org/10.1159/000328448
